A relationship between baseline MMP-9 levels and late HT has been established, where high baseline levels were predictive of late hemorrhagic events (Montaner et al., 2001c), further supported by the observation that MMP-9 levels were higher in patients who developed HT of their infarct (Heo et al., 2003). The gene discussed is MMP9; the disease is hematocrit.